Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The final coverage call After completing thorough clinical, affordability, and oversight evaluations, Capital Blue Cross decided to place oral Wegovy on the same formulary tier as the injectable version, reflecting comparable clinical value and similar expectations around appropriate use
Lancet Diabetes Endocrinol 2021;9:825-36.ArticlePubMed 129
Glucagon like peptide-1-induced glucose metabolism in differentiated human muscle satellite cells is attenuated by hyperglycemia
Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes
doi: 10.1016/j.tem.2019.07.004 24 CarusoICignarelliANatalicchioAPerriniSLaviolaLGiorginoF
US$ 23.15
US$ 25.63
US$ 25.34
US$ 27.09
